...
首页> 外文期刊>Clinics >Morphometric evaluation of NB84, synaptophysin and AgNOR is useful for the histological diagnosis and prognosis in peripheral neuroblastic tumors (pNTs)
【24h】

Morphometric evaluation of NB84, synaptophysin and AgNOR is useful for the histological diagnosis and prognosis in peripheral neuroblastic tumors (pNTs)

机译:NB84,突触素和AgNOR的形态计量学评估有助于周围神经母细胞瘤(pNTs)的组织学诊断和预后

获取原文
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To study the importance of NB84, synaptophysin and AgNOR and explore the quantitative association of these factors with diagnosis and outcome as well as the association between NB84 and AgNOR and other tumor and stromal factors in twenty-eight peripheral neuroblastic tumors. METHODS: We assessed AgNORs, NB84, synaptophysin and several other markers in tumor tissues from 28 patients with primary neuroblastic tumors. The treatment included: surgery for stage 1, chemotherapy and bone marrow transplantation for most of stages 3 and 4. Histochemistry, immunohistochemistry and morphometry were used to evaluate the amount of tumor staining for AgNOR, NB84 and synaptophysin; the outcome for our study was survival time until death due to recurrent neuroblastic tumors. RESULTS: Only stage (p
机译:目的:探讨NB84,突触素和AgNOR的重要性,探讨这些因素与诊断和预后的定量关系,以及NB84和AgNOR与其他肿瘤和基质因素在28例周围神经母细胞瘤中的关系。方法:我们评估了28例原发性神经母细胞瘤患者的肿瘤组织中的AgNOR,NB84,突触素和其他几种标志物。治疗包括:第1阶段的手术​​,第3和第4阶段的大部分的化疗和骨髓移植。组织化学,免疫组织化学和形态计量学用于评估AgNOR,NB84和突触素的肿瘤染色量;我们研究的结果是直至复发神经母细胞瘤死亡的生存时间。结果:仅阶段(p

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号